The overexpression of NLRP3 by 17β-estradiol (E2) inhibits the development of hepatocellular carcinoma cells, indicating that NLRP3 may play a protective function in hepatic malignancy [138]. The gene discussed is NLRP3; the disease is hepatocellular carcinoma.